BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/8/2015 12:00:00 PM | Browse: 523 | Download: 958
 |
Received |
|
2015-02-04 11:58 |
 |
Peer-Review Started |
|
2015-02-06 12:34 |
 |
To Make the First Decision |
|
2015-03-10 20:54 |
 |
Return for Revision |
|
2015-03-12 11:44 |
 |
Revised |
|
2015-03-19 21:38 |
 |
Second Decision |
|
2015-04-14 17:23 |
 |
Accepted by Journal Editor-in-Chief |
|
2015-04-14 22:45 |
 |
Accepted by Executive Editor-in-Chief |
|
2015-04-28 18:03 |
 |
Articles in Press |
|
2015-04-28 18:03 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2015-05-12 06:14 |
 |
Typeset the Manuscript |
|
2015-06-25 10:25 |
 |
Publish the Manuscript Online |
|
2015-07-08 12:01 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Allergy |
Manuscript Type |
Editorial |
Article Title |
Personalized targeted therapy for esophageal squamous cell carcinoma
|
Manuscript Source |
Invited Manuscript |
All Author List |
Xiaozheng Kang, Keneng Chen, Yicheng Li, Jianying Li, Thomas A D'Amico and Xiaoxin Chen |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Beijing Academic Leaders Program |
2009-2-17 |
Beijing Natural Science Foundation |
7102029 |
Capital Medical Developed Research Fund |
2007-1023 |
New Scholar Star Program of Ministry of Education |
|
National Basic Research Program of China |
2011CB504300 |
Specialized Research Fund for the Doctoral Program of Higher Education |
20130001110108 |
National Natural Science Foundation for Distinguished Young Scholars |
81301748 |
Science Fund for Creative Research Groups of the National Natural Science Foundation of China |
IRT13003 |
Science Fund for Creative Research Groups of the National Natural Science Foundation of China |
NIH/NCI U54 CA156735 |
|
Corresponding Author |
Xiaoxin Chen, MD, PhD, Cancer Research Program, Julius L. Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, 700 George Street, Durham, NC 27707, United States. lchen@nccu.edu |
Key Words |
Cancer heterogeneity; Cultured tumor cells; Driver mutation; Drug side effects; Esophageal squamous cell carcinoma; Exceptional responder; High-throughput nucleotide sequencing; Neoplasm drug resistance; Personalized medicine; Xenograft model |
Core Tip |
Esophageal squamous cell carcinoma re?presents a heavy burden on clinicians worldwide. Recently, researchers have discovered the genomic landscape of this cancer, which holds promise for an era of personalized oncology care. Evolving topics in personalized oncology, such as interpretation of genomics data, critical issues in targeted therapy, research approaches, and future perspectives, are discussed in this editorial. |
Publish Date |
2015-07-08 12:01 |
Citation |
Kang X, Chen K, Li Y, Li J, D’Amico TA, Chen X. Personalized targeted therapy for esophageal squamous cell carcinoma. World J Gastroenterol 2015; 21(25): 7648-7658 |
URL |
http://www.wjgnet.com/1007-9327/full/v21/i25/7648.htm |
DOI |
http://www.wjgnet.com/1007-9327/full/v21/i25/7648.htm |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345